Inovio Pharmaceuticals In... (INO)
NASDAQ: INO
· Real-Time Price · USD
1.86
0.24 (14.81%)
At close: Aug 15, 2025, 3:59 PM
1.89
1.61%
After-hours: Aug 15, 2025, 07:53 PM EDT
Inovio Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 24.35M | 39.92M | 65.81M | 21.69M | 34.39M | 19.6M | 14.31M | 18.8M | 52.71M | 28.24M | 46.33M | 21.99M | 41.1M | 59.01M | 71.14M | 67.94M | 58.93M | 83.63M |
Short-Term Investments | 23.2M | 28.45M | 28.3M | 63.12M | 76.03M | 86.01M | 130.98M | 148.67M | 142.21M | 195.51M | 206.67M | 259.89M | 307.02M | 301.38M | 330.17M | 327M | 384.75M | 434.97M |
Long-Term Investments | 3.09M | 2.31M | 1.61M | 2.64M | 2.32M | 2.65M | 2.78M | 2.99M | 2.78M | 2.62M | 2.01M | 2.13M | 2.44M | 3.37M | 3.91M | 3.89M | 3.91M | 3.63M |
Other Long-Term Assets | 2.01M | 1.98M | 1.98M | 566.41K | 585.91K | 605.32K | 605.32K | 605.32K | 666.89K | 652.52K | 684.04K | 701.99K | 770.14K | 1.27M | 1.43M | 1.76M | 1.83M | 25.88M |
Receivables | 840.31K | 1.31M | 1.2M | 1.86M | 1.77M | 2.55M | 2.41M | 2.14M | 5.12M | 5.04M | 11.74M | 10.08M | 11.37M | 7.49M | 8.03M | 7.13M | 13.85M | 10.26M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | n/a | n/a | n/a | n/a | 20.43K | 34.92K | 11.93K | 195.85K | 30.38M | n/a | n/a | n/a | 261.19K | n/a | n/a | n/a |
Total Current Assets | 52.7M | 71.89M | 97.83M | 91.28M | 117.56M | 111.68M | 153.11M | 174.77M | 203.28M | 233.9M | 315.24M | 350.21M | 416.19M | 399.91M | 448.44M | 487.4M | 542.42M | 588.43M |
Property-Plant & Equipment | 10.45M | 11.09M | 11.77M | 12.56M | 13.33M | 14.17M | 14.45M | 14.73M | 15.79M | 16.85M | 17.96M | 26.17M | 27.13M | 27.95M | 29.02M | 29.46M | 30.28M | 23.39M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.51M | 12.56M | 12.64M | 12.76M | 12.88M | 13.01M | 13.14M | 13.27M | 13.39M | 13.52M |
Total Long-Term Assets | 15.54M | 15.38M | 15.37M | 15.78M | 16.24M | 17.43M | 17.84M | 18.33M | 29.75M | 32.69M | 33.29M | 41.76M | 43.21M | 45.6M | 47.5M | 48.37M | 49.42M | 66.43M |
Total Assets | 68.24M | 87.27M | 113.2M | 107.06M | 133.8M | 129.11M | 170.95M | 193.1M | 233.04M | 266.58M | 348.53M | 391.97M | 459.4M | 445.51M | 495.94M | 535.76M | 591.84M | 654.86M |
Account Payables | 5.48M | 5.52M | 6.44M | 5.39M | 6.41M | 8.3M | 4.65M | 3.9M | 10.36M | 12.61M | 21.08M | 14.27M | 39.57M | 39.52M | 27.97M | 29.15M | 31.87M | 26.74M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.98M | 15.38K | 21.63K | 77.88K | 109.13K | 54.38K |
Short-Term Debt | 2.66M | n/a | n/a | n/a | n/a | 2.16M | 16.77M | 16.49M | 16.71M | 16.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 14.91M | 15.86M | 23.26M | 9.92M | 8.66M | 3.55M | 9.95M | 14.04M | 12.52M | 11.82M | 15.14M | 16.78M | 18.01M | 5.32M | 20.71M | 6M | 6.89M | 4.98M |
Total Current Liabilities | 31.71M | 27.33M | 35.33M | 23.5M | 26.4M | 23.4M | 42.57M | 43.71M | 51.93M | 55.15M | 96.87M | 94.91M | 131.06M | 59.36M | 65.74M | 51.38M | 51.75M | 41.54M |
Long-Term Debt | 8B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 16.61M | 16.3M | 16.52M | 16.21M | 14.96M | 14.48M | 14.54M | 14.07M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 710.35K | n/a | n/a | 14.83K | 101.64K | 101.64K | 101.64K |
Total Long-Term Liabilities | 8M | 8.7M | 9.37M | 10.02M | 10.66M | 11.27M | 11.03M | 11.23M | 11.73M | 12.22M | 29.3M | 30.36M | 30.66M | 31.07M | 30.53M | 30.81M | 31.54M | 31.72M |
Total Liabilities | 39.71M | 36.02M | 44.69M | 33.52M | 37.06M | 34.67M | 53.6M | 54.94M | 63.67M | 67.37M | 126.17M | 125.27M | 161.73M | 90.43M | 96.27M | 82.19M | 83.29M | 73.26M |
Total Debt | 10.66M | 11.27M | 11.87M | 12.45M | 12.98M | 13.43M | 30.21M | 29.8M | 30.76M | 31.16M | 32.07M | 32.43M | 33.31M | 33.65M | 33.02M | 33.15M | 33.8M | 33.9M |
Common Stock | 36.72K | 36.67K | 36.1K | 26.05K | 25.96K | 23.37K | 22.79K | 269.73K | 268.07K | 262.74K | 21.09K | 249.48K | 247.5K | 226.51K | 217.38K | 210.36K | 210.15K | 209.33K |
Retained Earnings | -1.77B | -1.75B | -1.73B | -1.71B | -1.69B | -1.65B | -1.62B | -1.6B | -1.56B | -1.53B | -1.49B | -1.43B | -1.4B | -1.29B | -1.21B | -1.1B | -1.04B | -960.6M |
Comprehensive Income | -661.74K | -661.32K | -675.67K | -623.46K | -689.54K | -676.21K | -662.6K | -751.07K | -691.26K | -582.8K | -698.74K | -885.21K | -649.66K | -457.89K | -282.24K | -257.93K | -265.91K | -265.71K |
Shareholders Equity | 28.53M | 51.25M | 68.5M | 73.54M | 96.74M | 94.44M | 117.35M | 138.16M | 169.37M | 199.21M | 222.36M | 266.7M | 297.67M | 355.09M | 399.67M | 453.57M | 508.55M | 581.61M |
Total Investments | 26.28M | 30.76M | 29.91M | 65.76M | 78.35M | 88.67M | 133.76M | 151.66M | 144.99M | 198.14M | 208.68M | 262.02M | 309.46M | 304.75M | 334.08M | 330.89M | 388.66M | 438.6M |